Metsios et al. who evaluated BC, ESR, CRP levels, and DAS28 scores before and after 12-week anti-TNF therapy showed that no significant change occurred, whereas marked improvement was achieved in disease activity with this treatment in 20 patients with RA43. The gene discussed is CRP; the disease is breast cancer.